Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene

Curr Rheumatol Rep. 2022 Jun;24(6):206-212. doi: 10.1007/s11926-022-01073-7. Epub 2022 Apr 18.

Abstract

Purpose of review: To provide an up-to-date approach to diagnosis and management of FMF patients.

Recent findings: Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease and prototype monogenic autoinflammatory recurrent fever syndrome. Although it is one of the well-known autoinflammatory disorders, evaluations in the etiopathogenesis and genetics of the disease have shown that FMF is more complex than previously known. Since the number of reported MEFV variants increased, evaluating the genetic test results has become more challenging. Here, we suggest a roadmap for clinicians to facilitate their decisions regarding diagnosis, treatment, and follow-up in FMF patients with different genotype-phenotype combinations. The correct interpretation of genetic test results is crucial for timely diagnosis, appropriate treatment, and follow-up of FMF patients.

Keywords: Diagnosis; Familial Mediterranean fever; Genetic; MEFV; Treatment.

Publication types

  • Review

MeSH terms

  • Familial Mediterranean Fever* / diagnosis
  • Familial Mediterranean Fever* / genetics
  • Humans
  • Mutation
  • Pyrin / genetics

Substances

  • MEFV protein, human
  • Pyrin